Local view for "http://purl.org/linkedpolitics/eu/plenary/2005-10-26-Speech-3-269"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20051026.18.3-269"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
".
As the honourable Member is aware, the Council is currently examining the Commission proposal of April 2005 for the Seventh Framework Programme for 2007-2013 – or FP7 – which will be decided by this Parliament and the Council under the codecision procedure.
The Council has, on several occasions, confirmed the importance it attaches to research and technological development activities in the context of the Lisbon Agenda. I hope the commitment of our own Prime Minister and the Presidency to that agenda was obvious to all Members of this Parliament from his remarks earlier this afternoon.
The research programme in particular is the main Community instrument. Further research into respiratory diseases would be timely. Respiratory diseases are currently the leading cause of death in the European Union and yet these illnesses have a lower profile than many other diseases such as heart disease.
The honourable Member is right to draw attention to the significant economic loss caused by these diseases in particular. In the European Union, 41 300 lost work days per one thousand of the population are due to chronic obstructive pulmonary disease alone.
Productivity losses resulting from this disease amount to EUR 28.5 billion annually. The Commission proposal for FP7 includes health and environment as priority research topics. As regards research potentially relevant to respiratory diseases, the following topics are proposed amongst others: innovative therapeutic approaches and intervention with potential applications in many diseases; transnational research into infectious diseases and major diseases including cancer; the quality, efficiency and solidarity of health systems; enhanced disease prevention and better use of medicines; the interaction of environmental factors such as pollution with human health.
The Framework Programme indicates the broad lines of research activity and therefore does not exhaustively list the potential individual research topics. These will be elaborated on in the specific programme decisions and during the execution of the programme, which is the responsibility of the Commission.
Research projects are selected mainly on the basis of open calls for proposals to the scientific community and take into account various criteria such as scientific excellence and European added value."@en1
|
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples